What the world needs to know about the bikini bottom gene
Genetic testing may soon offer more information on the bikini bottoms genetics.
Genomics company Invitae has developed a technology that could help detect genes associated with female body shapes and sizes.
According to Invitabe, the DNA sequencing of a bikini bottom is a unique genetic profile that can be used to reveal if a person is genetically similar to other women.
The company claims that the technology can be applied to detect genetic disorders and even diseases.
The technology is called the Biobased DNA Signature (BDS) system.
According to Invite, the system can detect the presence of multiple genes and proteins in a person’s DNA, making it an efficient screening tool.
Invitafe claims that it has developed an app to help people find out which genes are related to their body types.
In the video above, a person looks through the DNA profile of a woman in order to identify which genes may be associated with her bikini bottom.
The DNA is extracted from a woman’s body using a technique called DNA barcoding.
The company says that the method can be compared to the DNA barcodes that have been used in many clinical trials, such as that of the HPV vaccine.
The goal of the technology is to provide information on women’s body shape, size, and other traits, without having to use physical tests.
The app is also designed to provide a tool for researchers to help them identify diseases that affect women.
A video released by Invitave shows a woman with a bikini top looking through the profiles of other women and identifying genes associated to the bikini body.
The method was tested in the study by Invite in which participants were asked to look through the women’s profiles.
The results revealed that there were four genes that were linked to the shape of the bikini.
The researchers concluded that the women who were more similar to themselves than others had these genes.
In order to test if a woman has a bikini body type, the researchers used the DNA profiling technique.
Invite claims that their technology is able to identify between two to four million genes in a woman, without using physical tests or using genetic testing.
It is hoped that the new technology will lead to the development of new treatments for obesity and other diseases.
The technology is being developed in partnership with a number of other companies, including Aventis Health, which provides diagnostic testing to the health care industry.
Initiate said that it plans to release more detailed information about the technology at a conference in March.